Quantcast Genentech Announces Positive Results From Phase III Study Of Avastin - Congoo
 
 
BIOTECH Log In
Genentech Announces Positive Results From Phase III Study Of Avastin
Have an interest in this Story?
Sign Up for Real-Time email updates
RTTNews.com  | June 02, 2013

Genentech, a unit of the Roche Group (RHHBY.PK) announced the results of study which showed the addition of Avastin to chemotherapy extended the lives of women with advanced cervical cancer, compared to chemotherapy alone.The study met its primary endpoint of improving overall survival with a statis...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Melissa Keklak Melissa Keklak
Public Relations Manager
Marketing/Public Relations
Christopher O'Hara Christopher O'Hara
Senior Vice President
Online Marketing

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2014 Congoo.com. All Rights Reserved.